Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Melatonin has favorable preventive effects on experimental chronic pancreatitis rat model

Pages
2734–2740
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In light of these favorable positive results, melatonin may be a useful preventive agent in the course of CP.Key words: Chronic pancreatitis, rat, melatonin, endoplasmic reticulum, ABC transporter genes

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Currently, there is not any specific treatment for chronic pancreatitis (CP).
📊
Key Findings & Data:It was aimed to investigate the effects of melatonin administration on endoplasmic reticulum (ER) stress, oxidative stress, fibrosis, biochemical and histopathological parameters, and Abcc2,Abcc5, and Abcg2 gene levels in an experimental rat CP model.
💡
Conclusion & Impact:Conclusion: In light of these favorable positive results, melatonin may be a useful preventive agent in the course of CP.Key words: Chronic pancreatitis, rat, melatonin, endoplasmic reticulum, ABC transporter genes
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Currently, there is not any specific treatment for chronic pancreatitis (CP). It was aimed to investigate the effects of melatonin administration on endoplasmic reticulum (ER) stress, oxidative stress, fibrosis, biochemical and histopathological parameters, and Abcc2,Abcc5, and Abcg2 gene levels in an experimental rat CP model. Materials and methods: Forty rats were randomized into five groups: Sham, CP, CP+25 mg/kg melatonin, CP+50 mg/kg melatonin, and CP+placebo. In all rats, except the sham group, a model of chronic pancreatitis was accomplished with intraperitoneal caerulein administration. In treatment groups, melatonin was used as a therapeutic agent. Serum TGF-β, TNF-α, MDA and GPx levels were studied. Pancreatic tissues were evaluated histopathologically. The expression levels of αSma,IR1α,Perk,Abcc2,Abcc5, and Abcg2 genes were measured with the qRT-PCR. Results: Biochemical results of the melatonin groups exhibited favorable changes compared to the CP and placebo groups. αSma,IR1α,Perk expression levels were significantly lower in the melatonin groups. The expression levels of Abcc2, Abcc5, and Abcg2 were significantly higher in the CP group compared to the sham group, and these gene levels were significantly lower in the melatonin groups compared to the CP group (p < 0.01, p < 0.05, p < 0.05, respectively). Conclusion: In light of these favorable positive results, melatonin may be a useful preventive agent in the course of CP.Key words: Chronic pancreatitis, rat, melatonin, endoplasmic reticulum, ABC transporter genes

🔖

Cite This Article

TANOĞLU, A., ESEN, M. F., TANOĞLU, E. G., AYDIN, M. Ç. M. (2022). Melatonin has favorable preventive effects on experimental chronic pancreatitis rat model. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2734–2740. https://ajindex.com/articles/609457

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Yang D, Forsmark CE. Chronic pancreatitis. Current Opinion in Gastroenterology 2017
  2. 33 (5): 396-403. doi: 10.1097/ MOG.0000000000000377 2. Machicado JD, Amann ST, Anderson MA, Abberbock J, Sherman S et al. Quality of Life in Chronic Pancreatitis is Determined by Constant Pain, Disability/Unemployment, Current Smoking, and Associated Co-Morbidities. American Journal of Gastroenterology 2017
  3. 112 (4): 633-642. doi: 10.1038/ajg.2017.42 3. Wang L, Zeng YB, Chen JY, Luo Q, Wang R et al. A simple new scoring system for predicting the mortality of severe acute pancreatitis: A retrospective clinical study. Medicine (Baltimore) 2020
  4. 99 (23): e20646. doi: 10.1097/ MD.0000000000020646 4. Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology 2016
  5. 16 (2): 218-224. doi: 10.1016/j.pan.2016.02.001 5. Jaworek J, Leja-Szpak A, Nawrot-Porąbka K, Szklarczyk J, Kot M et al. Effects of Melatonin and Its Analogues on Pancreatic Inflammation, Enzyme Secretion, and Tumorigenesis. International Journal of Molecular Sciences 2017
  6. 18 (5). doi: 10.3390/ijms18051014 6. Goc Z, Szaroma W, Kapusta E, Dziubek K. Protective effects of melatonin on the activity of SOD, CAT, GSH-Px and GSH content in organs of mice after administration of SNP. Chinese Journal of Physiology 2017
  7. 60 (1): 1-10. doi: 10.4077/CJP.2017. BAF435 7. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M et al. Melatonin as an antioxidant: under promises but over delivers. Journal of Pineal Research 2016
  8. 61 (3): 253-278. doi: 10.1111/jpi.12360 8. Hameed EN, Hadi Al Tukmagi HF, Allami HCA. Melatonin Improves Erythropoietin Hyporesponsiveness via Suppression of Inflammation. Reviews on Recent Clinical Trials 2019
  9. Jaworek J, Leja-Szpak A, Kot M, Jaworek A, Nawrot-Porbka K et al. The role of melatonin in pancreatic protection: could melatonin be used in the treatment of acute pancreatitis? Current Pharmaceutical Design 2014
  10. 20 (30): 4834-4840. doi: 10.2174/1381612819666131119105019 10. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008
  11. 9 (1): 105-127. doi: 10.2217/14622416.9.1.105 11. O’Brien SJ, Omer E. Chronic Pancreatitis and Nutrition Therapy. Nutrition in Clinical Practice 2019
  12. 34 Suppl 1: 13-26. doi: 10.1002/ncp.10379 12. Apte M, Pirola RC, Wilson JS. Pancreatic stellate cell: physiologic role, role in fibrosis and cancer.